DR REDDYS LABORATORIES
Back to Income Statement
|
DR REDDYS LABORATORIES Last 5 Year Profit After Tax History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Profit After Tax | ₹5,578 Cr | ₹4,507 Cr | ₹2,183 Cr | ₹1,952 Cr | ₹2,026 Cr |
What is the latest Profit After Tax of DR REDDYS LABORATORIES ?
| Year | Profit After Tax |
|---|---|
| Mar2025 | ₹5,578 Cr |
| Mar2024 | ₹4,507 Cr |
| Mar2023 | ₹2,183 Cr |
| Mar2022 | ₹1,952 Cr |
| Mar2021 | ₹2,026 Cr |
How is Profit After Tax of DR REDDYS LABORATORIES Trending?
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2025 | ₹5,578 Cr | 23.75 | |
| Mar2024 | ₹4,507 Cr | 106.52 | |
| Mar2023 | ₹2,183 Cr | 11.83 | |
| Mar2022 | ₹1,952 Cr | -3.67 | |
| Mar2021 | ₹2,026 Cr | - | |
Compare Profit After Tax of peers of DR REDDYS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DR REDDYS LABORATORIES | ₹106,015.2 Cr | -3.1% | 4.8% | 10.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹442,893.0 Cr | -0.2% | 7.5% | 5.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹176,367.0 Cr | -0.9% | 11.5% | 9.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹148,241.0 Cr | 0.5% | 7% | 37.4% | Stock Analytics | |
| CIPLA | ₹104,366.0 Cr | -5.4% | 5.5% | -13.5% | Stock Analytics | |
| MANKIND PHARMA | ₹98,147.9 Cr | 0.7% | 15.7% | 1.6% | Stock Analytics | |
DR REDDYS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DR REDDYS LABORATORIES | -3.1% |
4.8% |
10.3% |
| SENSEX | -3.2% |
-3.9% |
-7.5% |
You may also like the below Video Courses